Viewing Study NCT05169957


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2025-12-29 @ 10:30 AM
Study NCT ID: NCT05169957
Status: COMPLETED
Last Update Posted: 2024-11-05
First Post: 2021-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module